Zydus
Zydus begins human trials for potential COVID-19 vaccine
In the human trials, Zydus will enrol over 1,000 subjects across multiple clinical study sites in India
Zydus receives USFDA nod for 2 products
The company has received final approval from the United States Food and Drug Adminstration (USFDA) to market generic Phytonadione tablets.
Pharma shows growth despite pre-GST fears
The organised pharma retail market continued the trend of steady upward rise this year despite pre-GST fears.
1 of 1